ATTBF — Abattis Bioceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Abattis Bioceuticals, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

	2015 September 30th	2016 September 30th	2017 September 30th	2018 September 30th	2019 September 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.251	0.038	0.526	9.1	2.4
Net Total Accounts Receivable
Net Total Receivables	0.039	0.039	0.128	0.568	0.175
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.349	0.091	0.679	10.5	3.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.166	0.149	0.53	0.725	0.757
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1.61	1.27	1.21	11.4	19.3
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.14	1.03	0.439	0.303	4.91
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	0.753	0.597	-0.314	-0.088	8.18
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.861	0.671	1.52	11.5	11.1
Total Liabilities & Shareholders' Equity	1.61	1.27	1.21	11.4	19.3
Total Common Shares Outstanding